date:May 15, 2014
based in Vevey, Switzerland, and Fresenius declined to comment.
Sales at the Danone unit, which includes Fortimel to counter malnutrition and Neocate, a hypoallergenic product for children, rose 5.2% in the first quarter on a like-for-like basis to 328 million. Revenue at the division was about 1.3 billion for all of last year, representing about 6% of the group total.
The unit gets 67% of sales from Europe and counts the U.K. and France as its two biggest markets.